Accordingly, augmented adiponectin production, for instance, in patients with advanced heart failure is assumably a compensatory mechanism due to the development of adiponectin resistance alike insulin resistance and hyperglycemia, which drive hyperinsulinemia [212]. This evidence concerns the gene ADIPOQ and Insulin resistance.